Xeris Biopharma Holdings, Inc. XERS Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s interest coverage?
- Xeris Biopharma Holdings, Inc. (XERS) reported interest coverage of 1.3× in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s interest coverage changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s interest coverage increased by 259.4% year-over-year, from -0.8× to 1.3×.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s interest coverage?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s interest coverage has grown at a -51.9% compound annual growth rate (CAGR), from -16× to 0.9×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.